Clinical trials
Phase 1/2 Lymphoma, Mantle-Cell trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Terminated | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| BeOne Medicines | 2 |
| Fred Hutchinson Cancer Center | 2 |
| ADC Therapeutics S.A. | 1 |
| Celgene | 1 |
| IGM Biosciences, Inc. | 1 |
| Loxo Oncology, Inc. | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| Southern Europe New Drug Organization | 1 |
| Swiss Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Mantle-Cell | 14 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 8 |
| Lymphoma, Follicular | 7 |
| Lymphoma, Large B-Cell, Diffuse | 7 |
| Lymphoma, Non-Hodgkin | 7 |
| Recurrence | 6 |
| Lymphoma | 5 |
| Lymphoma, B-Cell, Marginal Zone | 5 |
| Waldenstrom Macroglobulinemia | 4 |
| Burkitt Lymphoma | 3 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.